Barclays »

Soleno Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $858k 21k 40.27

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Soleno Therapeutics

Vivo Capital
Perceptive Advisors
Carlyle
Nantahala Capital Management
Henderson Group
Vanguard Group
Balyasny Asset Management
venBio Select Advisor
Commodore Capital
Ikarian Capital
Frazier Life Sciences Management
Samlyn Capital
Emerald Advisers
Wellington Management Company
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics